Healthcare >> CEO Interviews >> October 25, 2004
DR. WILLIAM G. GERBER has served as Chief Executive Officer of Epoch
Biosciences, Inc., since September 1999. From April 1998 until July
1999, Dr. Gerber served as President and Chief Executive Officer of
diaDexus LLC, a joint venture established by Incyte Pharmaceuticals and
SmithKline Beecham to apply genomic information and technologies to the
discovery of novel diagnostic products. Dr. Gerber served as Vice
President and Chief Operating Officer of Onyx Pharmaceuticals, a
biotechnology firm involved in the discovery of novel cancer
therapeutics, from June 1995 until April 1998 and as President of Chiron
Diagnostics from December 1991 until June 1995. Previously, he was
Senior Vice President and General Manager of the PCR Division with Cetus
Corporation. Dr. Gerber also has medical practice and managerial
experience in emergency medicine and founded an urgent care center
management company. He served on and was President of the Board of
Medical Quality Assurance, State of California. He received his MD and
BS from the University of California, San Francisco Medical Center after
attending Dartmouth College. Dr. Gerber is also on the Board of
Directors of Sangamo BioSciences, Inc. Profile
to Epoch?
Dr. Gerber: Epoch Biosciences started out under the name Microprobe in
1985. The company went public in 1993
